Momentum Bioscience
Unit 19 Willowbrook Technology Park Llandogo Road, St. Mellons, Cardiff, Wales, CF3 0EF, United Kingdom
Overview
Momentum Bioscience is developing a suite of technologies called Enzyme Mediated Amplification (EMA) for rapid detection of infection in blood, other normally sterile body fluids, and all living bacteria and fungi. The company is led by Chairman David Evans and CEO Bill Mullen and is based in Reading, UK. Momentum has built prototype products using its EMA platform. The company plans to use the recently raised funds to conduct clinical trials on those prototypes prior to completing product development and launch. The raise indicates an early-stage financing to advance clinical validation. No operating metrics were disclosed in the article.
- Total raised
- $0M
- Funding rounds
- 1
- Latest round
- Equity
- Latest activity
- Sep 2011
Industries
- Biotechnology
- Health Care
- Hospital
- Medical Device
- Venture Capital
Recent funding
Equity
Sep 2011
$0M
Team
No current team members are available.